共 16 条
[1]
Weiss SJ, Tissue destruction by neutrophils, N Engl J Med, 320, pp. 365-376, (1989)
[2]
McCall TB, Feelisch M, Palmer RMJ, Moncada S, Identification of N‐iminoethyl‐L‐ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells, Br J Pharmacol, 102, pp. 234-238, (1991)
[3]
Lee C, Kerrigan CL, Neutrophil localization following reperfusion of ischemic skin flaps, Plast Reconstr Surg, 89, pp. 910-915, (1992)
[4]
Lee C, Kerrigan CL, Picard-Ami LA, Cyclophosphamide induced neutropenia: effect on post‐ischemic skin flap survival, Plast Reconstr Surg, 89, pp. 1092-1097, (1992)
[5]
Palmer RMJ, Ashton DS, Moncada S, Vascular endothelial cells synthesize nitric oxide from L‐arginine, Nature, 333, pp. 664-666, (1988)
[6]
Moncada S, Palmer RMJ, Higgs EA, Nitric Oxide: Physiology, Pathophysiology and Pharmacology, Pharmacol Reviews, 43, 2, pp. 109-142, (1991)
[7]
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc Natl Acad Sci U S A, 87, pp. 1620-1624, (1990)
[8]
Stewart AG, Phan LH, Grigoriadis G, Physiological and pathophysiological roles of nitric oxide, Microsurgery, 15, pp. 693-702, (1994)
[9]
Szabo C, Mitchell JA, Thiemermann C, Vane JR, Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock, Br J Pharmacol, 108, pp. 786-792, (1993)
[10]
Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S, Identification of some novel inhibitors of the vascular nitric oxide synthase in vivo and in vitro, Br J Pharmacol, 101, pp. 746-752, (1990)

